Your session is about to expire
← Back to Search
Behavioural Intervention
Mobile Education App for Childhood Epilepsy
N/A
Recruiting
Led By Kenneth Alexis Myers, MD PhD FRCPC
Research Sponsored by McGill University Health Centre/Research Institute of the McGill University Health Centre
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 7 weeks
Awards & highlights
No Placebo-Only Group
Summary
"This trial aims to evaluate the effectiveness of a mobile application called MEEP in providing education, monitoring symptoms, and tracking medical appointments for families of children with epilepsy in Canada. The study will involve 72
Who is the study for?
This trial is for caregivers of children aged 1-17 with epilepsy treated at the Montreal Children's Hospital. It aims to help families manage anxiety and improve knowledge about epilepsy through a mobile app. Participants must be able to use the app in English or French.
What is being tested?
The study tests a Mobile Epilepsy Education Package (MEEP) against standard care. MEEP provides education, symptom monitoring, and appointment tracking via an app. Caregivers are randomly assigned to either receive MEEP or continue with usual educational services.
What are the potential side effects?
Since this trial involves an educational mobile application rather than medication, there are no direct medical side effects expected from participating in this study.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 7 weeks
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~7 weeks
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Change in epilepsy knowledge after 1 month of use of the Mobile Epilepsy Education Package
Secondary study objectives
Change in epilepsy anxiety after 1 month of use of the Mobile Epilepsy Education
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Group I: Standard care consisting of epilepsy educationExperimental Treatment1 Intervention
Standard care consisting of epilepsy education and support offered at the study setting by members of the Pediatric Neurology Clinic was chosen as the comparator and serves as the control group.
Group II: Mobile Epilepsy Education PackageExperimental Treatment1 Intervention
The Mobile Epilepsy Education Package (MEEP) consists of 2 parts. The first part entails the delivery of the "MEEP education", and the second part consists of the "Parental Monitoring Section". The intervention group will use MEEP for 4 weeks.
Find a Location
Who is running the clinical trial?
McGill University Health Centre/Research Institute of the McGill University Health CentreLead Sponsor
471 Previous Clinical Trials
166,885 Total Patients Enrolled
1 Trials studying Epilepsy
52 Patients Enrolled for Epilepsy
The Scientific and Technological Research Council of TurkeyOTHER
176 Previous Clinical Trials
23,612 Total Patients Enrolled
Ayfer Acikgoz, RN, PhDStudy ChairFaculty of Health Sciences, Eskisehir Osmangazi University
Argerie Tsimicalis, RN, PhDStudy ChairShriners Hospitals for Children, Ingram School of Nursing, McGill University
Kenneth Alexis Myers, MD PhD FRCPCPrincipal InvestigatorRI-MUHC, Montreal Children's Hospital, McGill University
Dilek Sayik, RN, PhDStudy ChairIngram School of Nursing, McGill University